Biotech Values : Imbruvica shows impressive duration of r...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Biotech Values

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	843
Posts	122897
Boards Moderated	9
Alias Born	09/05/2002

Re: ciotera post# 222405

Sunday, 12/02/2018 12:56:21 PM

Sunday, December 02, 2018 12:56:21 PM

Imbruvica shows impressive duration of response in CLL/SLL:

https://www.prnewswire.com/news-releases/imbruvica-ibrutinib-data-in-chronic-lymphocytic-leukemia-cll-show-up-to-seven-years-of-progression-free-survival-pfs-in-80-percent-of-previously-untreated-patients-the-longest-follow-up-for-a-brutons-tyrosine-kinase-inhib-300758683.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow